Signal Transduction by EGF Receptor Tyrosine Kinase

  • R. B. Lichtner
  • R. N. Harkins
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 19)


Members of the receptor tyrosine kinase family are frequently implicated in experimental models of neoplasia as well as in human cancer. One of the best studied receptor signaling systems from this family is the epidermal growth factor receptor (EGFR). The EGFR is widely expressed in mammals and has been implicated in various stages of embryonic development. Recently, EGFR knockout mice by targeted disruption of exon 1 (Sibilia and Wagner 1995) or exon 2 (Miettinen et al. 1995; Threadgill et al. 1995) of the mouse EGFR gene have been reported. The resulting phenotypes of EGFR-/- embryos or newborns were very similar. Growth retardation and epithelial immaturity were found, with the severity of defects being dependent on the mouse genetic background. These results indicate that the EGFR is of fundamental importance in the regulation of epithelial proliferation and differentiation. Experiments with transgenic mice suggest that an autocrine mechanism involving the EGFR could be expected to play a role in the initiation and/or progression of tumors. Transgenic mice expressing transforming growth factor-α (TGF-α) were reported to develop mammary and hepatocellular carcinoma as well as pancreatic hyperplasia (Jhappan et al. 1990; Sandgreen et al. 1990).


Epidermal Growth Factor Receptor Human Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Gene Epidermal Growth Factor Receptor Tyrosine Kinase erbB Receptor Family 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson D, Koch CA, Grey L, Ellis C, Moran MF, Pawson T (1990) Binding of SH2 domains of phospholipase C1, GAP, and src to activated growth factor receptors. Science 250: 979–982PubMedCrossRefGoogle Scholar
  2. Anklesaria P, Teixidó J, Laiho M, Pierce JH, Greenberger JS, Massagué J (1990) Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci USA 87: 3289–3293PubMedCrossRefGoogle Scholar
  3. Batra SK, Castelino-Prabhu S, Wikstrand CJ, Zhu X, Humphrey PA, Friedman HS, Bigner DD (1995) Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth Differ 6: 1251–1259PubMedGoogle Scholar
  4. Bellot F, Moolenar W, Kris R, Mirakhur B, Verlaan I, Ullrich A, Schlessinger J, Felder S (1990) High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody, and appears necessary for early responses. J Cell Biol 110: 491–502PubMedCrossRefGoogle Scholar
  5. Böni-Schnetzler M, Pilch PF (1987) Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding. Proc Natl Acad Sci USA 84: 7832–7835PubMedCrossRefGoogle Scholar
  6. Carraway III KL, Cantley LC (1994) A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78: 5–8PubMedCrossRefGoogle Scholar
  7. Daub, H, Weiss FU, Wallasch C, Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557–564.PubMedCrossRefGoogle Scholar
  8. David M, Wong L, Flavell R, Thompson SA, Wells A, Lamer AC, Johnson GR (1996) STAT activation by epidermal growth factor (EGF) and amphiregulin. J Biol Chem 271:9185–9188 .PubMedCrossRefGoogle Scholar
  9. Decker SJ (1993) Transmembrane signaling by epidermal growth factor receptors lacking autophosphorylation sites. J Biol Chem 268:9176–9179PubMedGoogle Scholar
  10. Defize LHK, Boonstra J, Meisenhelder J, Kruijer W, Tertoolen LGJ, Tilly BC, Hunter T, van Bergen en Henegouwen PMP, Moolenar WH, de Laat SW (1989) Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors. J Cell Biol 109: 2495–2507Google Scholar
  11. de Palazzo IEG, Adams GP, Sundaseshan P, Wong AJ, Testa JR, Bigner DD, Weiner LM. (1993) Expression of mutated epidermal growth factor receptor by non-small cell lung carcinoma. Cancer Res 53: 3217–3220Google Scholar
  12. Earp HS, Dawson TL, Li X, Yu H (1995) Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat 35: 115–132PubMedCrossRefGoogle Scholar
  13. Ekstrand AJ, Sugawa N, James CD, Collins VP (1992) Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 89: 4309–4313PubMedCrossRefGoogle Scholar
  14. Fedi P, Pierce JH, Difiore PP, Kraus MH (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase c- or GTPase-activating protein, distinguishes erbB-3 signaling from that of other erbB-EGFR family members. Mol Cell Biol 14: 492–500PubMedGoogle Scholar
  15. Feng GS, Pawson T (1994) Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduction. Trends Genet 10:54–58.PubMedCrossRefGoogle Scholar
  16. Feng GS, Hui CC, Pawson T (1993) SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases. Science 259:1607–1611PubMedCrossRefGoogle Scholar
  17. Gullick WJ (1991) Prevalence of aberrant expression of the epidermal growthfactor receptor in human cancers. Br Med Bull 47:87–98PubMedGoogle Scholar
  18. Gullick WJ (1994) A new model for the interaction of EGF-like ligands with their receptors: the new one-two. Eur J Cancer 30: 2186–2188CrossRefGoogle Scholar
  19. Harvey TS, Wilkinson AJ, Tappin MJ, Cooke RM, Campbell ID (1991) The solution structure of human transforming growth factor a. Eur J Biochem 198: 555–562PubMedCrossRefGoogle Scholar
  20. Honegger AM, Schmidt A, Ullrich A, Schlessinger J (1990) Evidence for epidermal growth factor receptor-induced intermolecular autophosphorylation of the EGF-receptors in living cells. Mol Cell Biol 10:4035–4044PubMedGoogle Scholar
  21. Hoyt DW, Harkins RN, Debanne MT, O’Connor-McCourt M, Sykes BD (1994) Interaction of transforming growth factor α with the epidermal growth factor receptor: finding kinetics and differential mobility within the bound TGF-α. Biochemistry 33:15283–15292PubMedCrossRefGoogle Scholar
  22. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH (1988) Amplification and expression of the epidermal growth-factor receptor gene in human glioma xenografts. Cancer Res 48: 2231–2238PubMedGoogle Scholar
  23. Hynes NE (1993) Amplification and overexpression of the c-erbB-2 gene in human tumors: its involvement in tumor development, its significance as a prognostic factor, and its potential as a target for cancer therapy. Semin Cancer Biol 4:19–26PubMedGoogle Scholar
  24. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker Mg, Korach KS, McLachlan JA (1993) Peptide growth factors elicit estrogen receptor dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 7:992–998PubMedCrossRefGoogle Scholar
  25. Ignar-Trowbridge DM, Pimantel M, Parker MG, McLachlan JA, Korach KS (1996) Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 137:1735–1744PubMedCrossRefGoogle Scholar
  26. Ihle JN (1996) STATs: signal transducers and activators of transcription. Cell 84:331–334PubMedCrossRefGoogle Scholar
  27. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Bioch Sci 19:222–227CrossRefGoogle Scholar
  28. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT (1990) TGF-a overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61: 1137–1146PubMedCrossRefGoogle Scholar
  29. Karunagaran D, Tzahar E, Beerli RB, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15:254–264PubMedGoogle Scholar
  30. Khazaie K, Dull TJ, Graf T, Schlessinger J, Ullrich A, Beug H, Vennström B (1988) Truncation of the human EGFR leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. EMBO J 7:3061–3071PubMedGoogle Scholar
  31. Lammers R, Bossenmaier B, Cool DE, Tonks K, Schlessinger J, Fischer EH, Ullrich A (1993) Differential activities of protein tyrosine phosphatases in intact cells. J Biol Chem 268:22456–22462PubMedGoogle Scholar
  32. Lemmon MA, Schlessinger J (1994) Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 19: 459–463PubMedCrossRefGoogle Scholar
  33. Lichtner RB, Wiedemuth M, Kittmann A, Ullrich A, Schirrmacher V, Khazaie K (1992) Ligand-induced activation of epidermal growth factor receptor in intact rat mammary adenocarcinoma cells without detectable receptor phosphorylation. J Biol Chem 267:11872–11880PubMedGoogle Scholar
  34. Mason S, Gullick WJ (1995) Type 1 growth factor receptors: an overview of recent developments. Breast 4: 11–18CrossRefGoogle Scholar
  35. Massoglia S, Gray A, Dull TJ, Munemitsu S, Kung H-J, Schlessinger J, Ullrich A (1990) Epidermal growth factor receptor cytoplasmic domain mutations trigger ligand-independent transformation. Mol Cell Biol 10:3048–3055PubMedGoogle Scholar
  36. McInnes C, Hoyt DW, Harkins RH, Debanne MT, O’Connor-McCourt M, Sykes BD (1996) NMR study of the transforming growth factor alpha/epidermal growth factor receptor complex: visualization of ligand binding determinants through NOE analysis of free and bound hTGFα. Biochemistry (in press)Google Scholar
  37. McLachlan JA, Nelson KG, Takahashi T, Bossert NL, Newborn RR, Korach KS (1991) Estrogens and growth factors in the development, growth, and function of the female reproductive tract. Schomberg DW (ed) Growth factors in reproduction. Springer, New York, pp 197–203CrossRefGoogle Scholar
  38. Miettinen PJ, Berger JE, Meneses J, Phung Y, Pederson RA, Werb Z, Derynck R (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376: 337–341PubMedCrossRefGoogle Scholar
  39. Modjtahedi H, Dean C (1994) The receptor for EGF and its ligands: expression prognostic value and target for therapy in cancer. Int J Oncol 4:277–296PubMedGoogle Scholar
  40. Montgomery RB, Moscatello DK, Wong AJ, Cooper JA, Stahl WL (1995) Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor. J Biol Chem 270: 30562–30566PubMedCrossRefGoogle Scholar
  41. Mooney RA, Freund GG, Way BA, Bordell KL (1992) Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growth factor and insulin-like growth factor. J Biol Chem 267:23443–23446PubMedGoogle Scholar
  42. Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ (1995) Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 55:5536–5539PubMedGoogle Scholar
  43. Moy FJ, Li Y- C, Ravenbuehler P, Winkler ME, Scheraga HA, Montelione GT (1993) Solution structure of human type-α transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints. Biochemistry 32:7334–7353PubMedCrossRefGoogle Scholar
  44. Nicholson S, Halcrow P Jr, Sainsbury C, Angus B, Chambers P, Farnon JR, Harris AL (1988) Epidermal growth factor receptor (EGFR) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer. Br J Cancer 58:810–814PubMedCrossRefGoogle Scholar
  45. Panayotou G, End P, Aumailley M, Timpl R, Engel H (1989) Domains of laminin with growth factor activity. Cell 56: 93–101PubMedCrossRefGoogle Scholar
  46. Prigent SA, Lemoine NR (1992) The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 4:1–24PubMedCrossRefGoogle Scholar
  47. Riese DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF (1996) Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin. Oncogene 12: 345–353PubMedGoogle Scholar
  48. Sadowski HB, Shuai K, Darnell JE, Gilman MZ (1993) A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739–1742PubMedCrossRefGoogle Scholar
  49. Sainsbury JRC, Farnon JR, Needham GK, Malcolm AJ, Harris AL (1987) Epidermal-growth factor receptor states as predictor of early recurrence of and death from breast cancer. Lancet i: 1398–1402Google Scholar
  50. Sandgreen EP, Luettke NC, Palmiter RD, Brinster RL, Lee DC (1990) Overexpression of TGF-a in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121–1135CrossRefGoogle Scholar
  51. Sherill JM, Kyte J (1996) Activation of epidermal growth factor receptor by epidermal growth factor. Biochemistry 35: 5705–5718CrossRefGoogle Scholar
  52. Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ, Darnell JE (1993) Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 366:580–582PubMedCrossRefGoogle Scholar
  53. Shum L, Reeves SA, Kuo AC, Fromer ES, Derynck R (1994) Association of the transmembrane TGF-a precursor with a protein kinase complex. J Cell Biol 125: 903–916PubMedCrossRefGoogle Scholar
  54. Sibilia M, Wagner EF (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269: 234–238PubMedCrossRefGoogle Scholar
  55. Silvennoinen O, Schindler C, Schlessinger J, Levy DE (1993) Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 261:1736–1739PubMedCrossRefGoogle Scholar
  56. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182PubMedCrossRefGoogle Scholar
  57. Soler C, Beguinot L, Carpenter G (1994) Individual epidermal growth factor receptor autophosphorylation sites do not stringently define association motifs for several SH2-containing proteins. J Biol Chem 269: 12320–12324PubMedGoogle Scholar
  58. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230–234PubMedCrossRefGoogle Scholar
  59. Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov E, Ullrich A, Böhmer F-D (1995) Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. J Biol Chem 270:21277–21284PubMedCrossRefGoogle Scholar
  60. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203–212PubMedCrossRefGoogle Scholar
  61. van Bergen en Henegouwen PMP, Defize LHK, de Kroon J, van Damme H, Verkleij AJ, Boonstra J (1989) Ligand-induced association of epidermal growth factor receptor to the cytoskeleton of A431 cells. J Cell Biochem 39:455–465PubMedCrossRefGoogle Scholar
  62. Wada T, Qian X, Greene MI (1990) Intermolecular association of the p 185neu protein and EGF receptor modulates EGF receptor function. Cell 61: 1339–1347PubMedCrossRefGoogle Scholar
  63. Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein B (1992) Structural alterations of the epidermal growth factor gene in human gliomas. Proc Natl Acad Sci USA 89: 2965–2969PubMedCrossRefGoogle Scholar
  64. Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M (1988) Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8: 1816–1820PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • R. B. Lichtner
  • R. N. Harkins

There are no affiliations available

Personalised recommendations